Overview
Fluticasone propionate is a synthetic glucocorticoid. These drugs are available as inhalers, nasal, sprays, and topical treatments for various inflammatory indications. Fluticasone propionate was first approved in 1990.
Indication
Fluticasone propionate is indicated as an inhaler for the treatment and management of asthma by prophylaxisas well as inflammatory and pruritic dermatoses. Fluticasone propionate nasal spray is indicated for managing allergic and nonallergic rhinitis.
Associated Conditions
- Allergic Rhinitis (AR)
- Allergy to Animal Dander
- Allergy to Mold
- Allergy to Tree Pollen
- Asthma
- Bacterial Sinusitis
- Chronic Bronchitis
- Chronic Obstructive Pulmonary Disease (COPD)
- Chronic Sinusitis
- Dermatitis
- Emphysema
- Eosinophilic Esophagitis
- House Dust Mite Allergy
- House dust allergy
- Itching of the nose
- Nasal Congestion
- Non-Allergic Rhinitis
- Rhinitis
- Rhinitis Perennial
- Rhinorrhoea
- Seasonal Allergic Rhinitis
- Sneezing
- Moderate, severe Perennial Allergic Rhinitis (PAR)
- Moderate, severe Seasonal Allergic Rhinitis
Clinical Trials
View More Clinical Trials
Sign in to access the complete clinical trial database with detailed study information.
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2012/05/25 | Phase 3 | Completed | |||
2012/04/16 | Phase 2 | Completed | |||
2012/04/12 | Phase 2 | Completed | |||
2012/04/10 | Phase 2 | Completed | |||
2012/03/26 | Phase 2 | Completed | |||
2012/03/15 | Phase 4 | Terminated | |||
2012/02/23 | Not Applicable | Completed | |||
2012/02/03 | Phase 4 | Completed | Professor Warren Lenney | ||
2012/01/24 | Phase 2 | Completed | Dey | ||
2012/01/24 | Phase 2 | Completed | Dey |
FDA Drug Approvals
View More FDA Approvals
Sign in to access additional FDA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| A-S Medication Solutions | 50090-2484 | NASAL | 50 ug in 0.1 g | 10/9/2020 | |
| A-S Medication Solutions | 50090-4211 | RESPIRATORY (INHALATION) | 100 ug in 1 1 | 1/7/2019 | |
| Mylan Pharmaceuticals Inc. | 0378-9321 | RESPIRATORY (INHALATION) | 250 ug in 1 1 | 1/8/2019 |
EMA Drug Approvals
View More EMA Approvals
Sign in to access additional EMA-approved drug information with detailed regulatory data.
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
View More HSA Approvals
Sign in to access additional HSA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
View More NMPA Approvals
Sign in to access additional NMPA-approved drug information with detailed regulatory data.
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
View More PPB Approvals
Sign in to access additional PPB-approved drug information with detailed regulatory data.
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
View More TGA Approvals
Sign in to access additional TGA-approved drug information with detailed regulatory data.
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.